Pharmaline, Lebanon   Report issue

For profit Phase 4
Founded: Beirut Lebanon (1978)
Status: No NME R&D (1978)

Organization Overview

First Clinical Trial
2008
NCT01008345
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

ezetimibe (zetia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1